News

News
Partner news

Minerva Neurosciences, Inc. Prices IPO below Range, Debuts at $6 per Share

Read full story
JNJ Press releases

Johnson & Johnson Innovation Announces Immuno-Oncology Lung Cancer Collaboration with the Dana-Farber Cancer Institute’s Belfer Institute for Applied Cancer Science

Read full story
JNJ Press releases

Johnson & Johnson Innovation Catalyzes New and Exciting Science and Technology in Pharmaceutical, Medical Device, Diagnostic and Consumer Healthcare Spaces

Read full story
Partner news

Navitor Pharmaceuticals Launches with $23.5 Million Series A Financing

Read full story
Partner news

Aduro BioTech Secures $55 Million Series C Financing

Read full story
Partner news

CVRx® Achieves Two Significant Milestones for its Heart Failure and Hypertension Businesses

Read full story
Partner news

Inspire Medical Systems Raises $40 Million in Series E Funding

Read full story
Partner news

Atlas Completes Final Tranche of £16.9 Million Series B Fundraising

Read full story
Partner news

Aquinox Pharmaceuticals Announces Closing of Initial Public Offering

Read full story
Partner news

Genocea Biosciences, Inc. Announces Closing of Initial Public Offering

Read full story
Partner news

Celladon Announces Pricing of Initial Public Offering

Read full story
Partner news

PowerVision Raises $30 Million in Series D Financing

Read full story
JNJ Press releases

Johnson & Johnson Innovation Expands Global Incubator Presence to Israel and Announces Multiple, Diverse, Early-Stage Collaborations with Academia and Biotech

Read full story
Partner news

Johnson & Johnson Innovation Expands Global Incubator Presence to Israel and Announces Multiple, Diverse, Early-Stage Collaborations with Academia and Biotech

Read full story
Partner news

Barostim Therapy™ Projected to be Cost-Effective in Treating Resistant Hypertension

Read full story